Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 331 AL 345

Exploring the nexus: Sleep disorders, circadian dysregulation, and Alzheimer's disease

Khandayataray P, Murthy MK.

Neuroscience. 2025 May 14;574:21-41. doi: 10.1016/j.neuroscience.2025.03.066. Epub 2025 Apr 4.

The mechanism underlying streptozotocin injection for the development of a nontransgenic Alzheimer's disease animal model

Titisari N, Ahmad H, Samsulrizal N, Fauzi A, Abdul Razak IS.

Open Vet J. 2025 Feb;15(2):594-600. doi: 10.5455/OVJ.2025.v15.i2.8. Epub 2025 Feb 28.

Harnessing marine resources for Alzheimer's therapy: A review integrating bioactivity and molecular docking

Khalid H, Mohamed H, Eltoukhy A, Saeed MT, Song Y.

Eur J Pharmacol. 2025 Jun 15;997:177611. doi: 10.1016/j.ejphar.2025.177611. Epub 2025 Apr 9.

Exploring Retinal Neurodegeneration in Alzheimer's Disease: A Molecular and Cellular Perspective

Dhapola R, Sharma P, Kumari S, Vellingiri B, Medhi B, HariKrishnaReddy D.

Neurotox Res. 2025 Apr 12;43(2):22. doi: 10.1007/s12640-025-00744-4.

Potential Benefits of Quercetin through P2X7 Modulation against Neuroinflammation in Alzheimer's Disease

Bianchini MC, Franscescon F, Soares AA, Ansolin V, Pretto KP, da Cunha MLV, de Resende E Silva DT.

Curr Neuropharmacol. 2025;23(11):1367-1379. doi: 10.2174/011570159X355614250130100132.

Photodynamic and Photothermal Therapies using Nanotechnology Approach in Alzheimer's Disease

Ozturk B, Demir H, Gunay MS, Akdag Y, Sahin S, Gulsun T.

Curr Neuropharmacol. 2025;23(14):1985-2003. doi: 10.2174/011570159X370790250317045223.

Past, present, and future of serotonin-targeting therapeutics for Alzheimer's disease: Perspectives from DNA methylation

Liu Y, Aquili L, Wong KH, Lu Z, Lim LW.

Ageing Res Rev. 2025 Jun;108:102755. doi: 10.1016/j.arr.2025.102755. Epub 2025 Apr 14.

Impact of corticoid receptors on Alzheimer's disease: a neuroendocrine perspective

Goel F, Kumar D, Sharma A.

Inflammopharmacology. 2025 May;33(5):2641-2656. doi: 10.1007/s10787-025-01734-w. Epub 2025 Apr 18.

NLRP3 inflammasome in Alzheimer's disease: molecular mechanisms and emerging therapies

Li Z, Gong C.

Front Immunol. 2025 Apr 7;16:1583886. doi: 10.3389/fimmu.2025.1583886. eCollection 2025.

Butyrate: a key mediator of gut-brain communication in Alzheimer's disease

Kachoueiyan F, Kalkhoran NY, Kalkhoran AY, Kyada A, Rekha MM, Chaudhary K, Barwal A, Sead FF, Joshi KK.

Metab Brain Dis. 2025 Apr 23;40(5):189. doi: 10.1007/s11011-025-01617-7.

Apolipoprotein E in Alzheimer's disease: molecular insights and therapeutic opportunities

Belaidi AA, Bush AI, Ayton S.

Mol Neurodegener. 2025 Apr 24;20(1):47. doi: 10.1186/s13024-025-00843-y.

Molecular dynamics of amyloid-β transport in Alzheimer's disease: Exploring therapeutic plasma exchange with albumin replacement - Current insights and future perspectives

Mondal R, Deb S, Shome G, Sarkar V, Lahiri D, Datta SS, Benito-León J.

Neurologia (Engl Ed). 2025 Apr;40(3):306-328. doi: 10.1016/j.nrleng.2025.03.008.

Extracellular vesicles as therapeutic modulators of neuroinflammation in Alzheimer's disease: a focus on signaling mechanisms

Han J, Zhang X, Kang L, Guan J.

J Neuroinflammation. 2025 Apr 25;22(1):120. doi: 10.1186/s12974-025-03443-1.

Iatrogenic Dementia: Providing Insight into Transmissible Subtype of Alzheimer's Disease, Creutzfeldt-Jakob Disease and Cerebral Amyloid Angiopathy

Karatzetzou S, Ioannidis S, Konstantinopoulou E, Parisis D, Afrantou T, Ioannidis P.

Biomolecules. 2025 Apr 3;15(4):522. doi: 10.3390/biom15040522.

Role of Ion Channels in Alzheimer's Disease Pathophysiology

Bhoi R, Mitra T, Tejaswi K, Manoj V, Ghatak S.

J Membr Biol. 2025 Jun;258(3):187-212. doi: 10.1007/s00232-025-00341-8. Epub 2025 May 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias